(2,5-difluorophenyl)sulfonyl-[2-(1-ethyl-4-pyridin-4-ylpyrazol-3-yl)-4-fluorophenyl]carbamic acid
C23H17F3N4O4S — CID 71071930
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2,5-difluorophenyl)sulfonyl-[2-(1-ethyl-4-pyridin-4-ylpyrazol-3-yl)-4-fluorophenyl]carbamic acid
(2,5-difluorophenyl)sulfonyl-[2-(1-ethyl-4-pyridin-4-ylpyrazol-3-yl)-4-fluorophenyl]carbamic acid (PubChem CID 71071930) has the molecular formula C23H17F3N4O4S and a molecular weight of 502.47 g/mol. Its IUPAC name is (2,5-difluorophenyl)sulfonyl-[2-(1-ethyl-4-pyridin-4-ylpyrazol-3-yl)-4-fluorophenyl]carbamic acid.
Molecular Properties
| Compound Name | (2,5-difluorophenyl)sulfonyl-[2-(1-ethyl-4-pyridin-4-ylpyrazol-3-yl)-4-fluorophenyl]carbamic acid |
|---|---|
| PubChem CID | 71071930 |
| Molecular Formula | C23H17F3N4O4S |
| Molecular Weight | 502.47 g/mol |
| Exact Mass | 502.09 |
| IUPAC Name | (2,5-difluorophenyl)sulfonyl-[2-(1-ethyl-4-pyridin-4-ylpyrazol-3-yl)-4-fluorophenyl]carbamic acid |
| SMILES | CCn1cc(-c2ccncc2)c(-c2cc(F)ccc2N(C(=O)O)S(=O)(=O)c2cc(F)ccc2F)n1 |
| InChI | InChI=1S/C23H17F3N4O4S/c1-2-29-13-18(14-7-9-27-10-8-14)22(28-29)17-11-15(24)4-6-20(17)30(23(31)32)35(33,34)21-12-16(25)3-5-19(21)26/h3-13H,2H2,1H3,(H,31,32) |
| InChIKey | YZQCPLXDBPXWFQ-UHFFFAOYSA-N |
| XLogP | 4.92 |
| TPSA | 105.39 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.47 |
| LogP ≤ 5 | 4.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71071930 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.